| Literature DB >> 33530649 |
Tilman Ahlfeld1, Anja Lode1, Richard Frank Richter1, Winnie Pradel2, Adrian Franke2, Martina Rauner3, Bernd Stadlinger4, Günter Lauer2, Michael Gelinsky1, Paula Korn5.
Abstract
Cleft alveolar bone defects can be treated potentially with tissue engineered bone grafts. Herein, we developed novel biphasic bone constructs consisting of two clinically certified materials, a calcium phosphate cement (CPC) and a fibrin gel that were biofabricated using 3D plotting. The fibrin gel was loaded with mesenchymal stromal cells (MSC) derived from bone marrow. Firstly, the degradation of fibrin as well as the behavior of cells in the biphasic system were evaluated in vitro. Fibrin degraded quickly in presence of MSC. Our results showed that the plotted CPC structure acted slightly stabilizing for the fibrin gel. However, with passing time and fibrin degradation, MSC migrated to the CPC surface. Thus, the fibrin gel could be identified as cell delivery system. A pilot study in vivo was conducted in artificial craniofacial defects in Lewis rats. Ongoing bone formation could be evidenced over 12 weeks but the biphasic constructs were not completely osseous integrated. Nevertheless, our results show that the combination of 3D plotted CPC constructs and fibrin as suitable cell delivery system enables the fabrication of novel regenerative implants for the treatment of alveolar bone defects.Entities:
Keywords: 3D printing; biofabrication; bone; bone tissue engineering; calcium phosphate cement; cleft alveolar osteoplasty; fibrin; mesenchymal stem cells; rat model
Mesh:
Substances:
Year: 2021 PMID: 33530649 PMCID: PMC7865817 DOI: 10.3390/ijms22031218
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923